# Fin Risk Analyst

- Symbol: ALAB
- Elapsed: 19.7s

---
I have sufficient data across credit, liquidity, market, and cash-flow dimensions. Two notes before the analysis: the pricing/ratio tools reference **FY2025 (period end 2025-12-31)** as the latest *annual* period, but quarterly filings through **Q2 2026** are available and show continued rapid growth — I use both. Credit ratings/CDS are not available (and largely moot given the capital structure).

---

# ALAB (Astera Labs) — Financial Risk Assessment

## 1. Credit Risk Assessment

**Rating: Investment Grade (net-cash, effectively de-risked).**

ALAB carries almost no debt. Total debt is **$35.1M** (essentially operating/finance leases) against **$1.19B of cash & short-term investments**, yielding a **net cash position of ~$1.15B** and a **net debt/EBITDA of −5.13x**. Debt/equity is **0.03**, debt/assets **0.02**. With **zero interest expense** in FY2025, interest coverage is effectively infinite (no debt service obligation). There is no refinancing cliff and no covenant exposure. The credit risk here is not solvency — it is *equity* risk in a high-multiple, high-beta name.

## 2. Key Financial Risk Metrics

| Metric | Value | Read |
|---|---|---|
| Debt / Equity | 0.03 | Minimal leverage |
| Net Debt / EBITDA | −5.13x | Net cash |
| Interest Coverage | N/A (no interest expense) | No debt service |
| Current Ratio | 10.24 | Exceptional |
| Quick Ratio | 9.79 | Exceptional |
| Cash Ratio | 8.94 | Exceptional |
| Cash & ST Inv. | $1.19B | 89% of assets |
| Working Capital | $1.23B | Very strong |
| Altman Z-Score | 6.86 (Safe zone) | Far above 2.99 |
| Piotroski F-Score | 6 / 9 (Moderate) | See red flags |
| Operating Margin (FY25) | 20.3% | Profitable, scaling |
| FCF (FY25) | $281.8M | FCF margin ~33% |
| FCF Yield | 0.55% | Thin vs. valuation |
| FY25 Revenue | $852.5M (+115% YoY) | Hyper-growth |

**Trend:** Revenue inflected from $115.8M (FY23) → $396.3M (FY24) → $852.5M (FY25), and quarterly revenue is still compounding ($230.6M Q3'25 → $270.6M Q4'25 → $308.4M Q1'26 → $392.4M Q2'26). Operating leverage is now real (FY24 op loss −$116M → FY25 op income +$173M). FCF margin improved from 25.8% to 33.1%.

## 3. Market Risk Profile

| Metric | Value |
|---|---|
| Annualised Volatility (1yr) | **98.0%** |
| Beta vs SPY | **3.79** |
| Max Drawdown (trailing) | **−55.5%** |
| Sharpe Ratio (rf=0) | 0.84 |

This is a *very* high-risk equity. Beta of ~3.8 means a 10% market drawdown implies roughly a **~38% move** in ALAB — the stock is a leveraged play on AI-capex sentiment. Realized drawdowns confirm this: the stock fell from ~$252 (Sep-2025) to ~$139 (Nov-2025), then round-tripped, and the trailing-year max drawdown registered **−55.5%**. The 0.84 Sharpe is respectable *for the return earned* but is entirely dependent on the AI datacenter cycle staying intact. Volatility near 100% means position-sizing/downside tolerance should dominate any credit narrative.

## 4. Downside Scenario Analysis — Revenue −20%

Applied to FY2025 base ($852.5M), assuming gross margin holds at ~75.7% and opex is ~70% fixed:

| Line | Base FY25 | Scenario (−20% rev) |
|---|---|---|
| Revenue | $852.5M | $682.0M |
| Gross Profit (75.7%) | $645.3M | $516.3M |
| Opex (≈$472M, 70% fixed) | $471.8M | ~$436M |
| **Operating Income** | $173.4M | **~$80M** (still positive, ~11.7% margin) |
| Interest income (~4% on $1.19B) | ~$48M | ~$48M |
| **Net Income** | $219.1M | **still solidly positive** |
| FCF | $281.8M | Positive (est. ~$130M+) |

**Conclusion:** Even a severe 20% revenue shock leaves ALAB solidly profitable and free-cash-flow positive, with **zero debt service and >$1B cash buffer**. There is **no solvency, liquidity, or covenant risk** in this scenario. A harsher −40% shock would push operating income toward breakeven, but the net-cash balance sheet absorbs it and cash runway is effectively indefinite. The downside is to **valuation multiple and share price**, not to the balance sheet.

## 5. Overall Financial Risk Rating: **MODERATE**

Balance-sheet risk is **Low** (net cash, no debt, elite liquidity, Safe-zone Z-score). But the *equity* risk is **High/Critical** given 98% volatility, 3.8 beta, and −55% peak-to-trough drawdowns. Blended, the financial-risk rating is **Moderate** — the company will survive any plausible downturn; shareholders may not enjoy the ride.

## 6. Key Red Flags

- **Extreme market risk.** Beta 3.79, vol ~98%, −55.5% trailing max drawdown. This is the dominant risk — not credit.
- **Thin FCF yield (0.55%).** Valuation embeds near-perfect execution; any growth deceleration compresses the multiple violently.
- **Heavy stock-based compensation.** $160M SBC in FY25 (~19% of revenue) drives dilution — Piotroski lost the "no dilution" point (F7) and share count rose (~166M→172M basic). F-Score of 6 reflects this plus a flat-to-declining gross margin (76.4%→75.7%, F8) and rising absolute debt (leases, F5).
- **Cyclical / concentrated end-market.** Revenue is tied to AI/hyperscaler datacenter capex — inherently pro-cyclical and likely customer-concentrated (concentration detail not in feed). A capex pause is the true downside vector.

**Data gaps flagged:** Credit rating and CDS spreads unavailable (and moot — no meaningful debt). Price history feed ends 2025-12-31 while the profile price ($286.69) and vol/beta metrics reflect a later date, implying a large 2026 rally; the ~$287 price vs. $166 year-end close means recent returns are not fully captured in the daily series I pulled. Customer-concentration and debt-maturity-schedule detail are not exposed by the tools; I treat both as immaterial to credit given the net-cash position.
